Canon Communications Announces Details of Drug Development SummitLOS ANGELES--(BUSINESS WIRE)--Jan 28, 2008 - The Pharmaceutical Media Group of Canon Communications today announced further details of its leading event for research and design professionals in the pharmaceuticals industry--the fifth annual Drug Development Summit, February 12-15, 2008 at the Ritz Carlton Hotel, in Amelia Island, FL.
Every year, the editors of Canon's R&D Directions magazine publish a list of the pharmaceutical companies they believe represent the industry's "Top 10 Pipelines." The issue featuring the Top 10 Pipelines cover story will be published this month. In addition to the cover story, R&D Directions has organized the Drug Development Summit--a unique, three-day conference to feature keynote presentations from the "Top 10 Pipelines" winners.
The summit was designed to present a strategic approach to tackling R&D's critical issues in 2008 and provide a forum for senior level research and development executives to share insights and lessons, compare strategies, and make connections with key opinion leaders while discussing the decisions and strategies that led to their winning pipelines. It is truly a unique event, with a scale and format that encourages maximum interaction and lively debate.
The Summit's list of keynote speakers includes:
-- Alejandro Aruffo, Vice President, Global Development, Abbott Laboratories
-- Jan M. Lundberg, PhD, Executive Vice President Global Discovery Research, AstraZeneca
-- Brian Daniels, Senior Vice President Global Clinical Development, Bristol-Myers Squibb Co.
-- Seigo Izumo, Global Head of Cardiovascular Research for the Novartis Institutes for BioMedical Research (NIBR), Novartis
-- Kapil Dhingra, MD, Vice President and Disease Biology Leader - Oncology, Roche
-- Robert R. Ruffolo, Jr, PhD, President, Research and Development, Wyeth Pharmaceuticals, and Senior Vice President, Wyeth Corporation
Topics that will be presented during the three day event include: Regulatory Priorities for 2008: Weighing the Risks, Collaborative Strategies to Revitalize Pipelines, Optimizing R&D Productivity, and Expediting Drug Development & Accelerating Approvals. More information and online registration can be found at www.drugdevelopmentsummit.com.
About Canon Communications
Canon Communications LLC, a portfolio company of Apprise Media LLC (www.apprisemedia.com), is the leading publisher, trade show producer, and digital media company for the world's $3 trillion advanced, technology-based manufacturing industry, including medical device, packaging, design engineering, process technology, automated assembly, electronics, quality control, and plastics processing. Information about Canon's products is available at www.cancom.com.
Christine Gaudet, 215-944-9808
Posted: January 2008